Non-Cochrane · aetiology · PM36232165

Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A Systematic Review and Meta-Analysis.

Lam Phoebe Pui Ying, Zhou Ni, Wong Hai Ming, et al. · International journal of environmental research and public health · 2022 · PubMed · doi:10.3390/ijerph191912864

Oral HealthDental cariesAMSTAR 2: not applicable
Full textEvery question was extracted from the full text, figures and supplements by two independent LLM extractors, disagreements adjudicated. Rows cite where in the review the value comes from.
Questions
25
current version
GRADE rated
0
No studies
3
Included studies
21
linked below
No studies 3 · 12%Ungraded 22 · 88%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationChildren and adolescents below 18 yearsChildren and adolescents (<18 years); 1002 HIV-infected subjects and 975 healthy controls across 12 studies (n=1977)
InterventionUndergoing antiretroviral therapy (ART) or highly active antiretroviral therapy (HAART) for HIVART/HAART (12 studies)
ComparisonHealthy HIV-negative controlsHealthy HIV-negative controls (siblings or school/clinic controls)
OutcomesDental caries (prevalence and severity); oral hygiene and periodontal health; HIV-related orofacial diseases by WHO clinical staging (stage 2: angular cheilitis, herpes zoster, linear gingival erythema, recurrent oral ulcerations, parotid enlargement; stage 3: oral candidiasis, oral hairy leukoplakia, acute necrotizing ulcerative gingivitis/periodontitis; stage 4: herpes simplex infection, Kaposi sarcoma); salivary immunoglobulins; oral candidiasis; dental developmentCaries prevalence (2 studies); caries severity (1); oral hygiene (1); periodontal disease (2); angular cheilitis (2); linear gingival erythema (2); recurrent oral ulceration (3); parotid enlargement (1); oral candidiasis (5); oral hairy leukoplakia (2); hyperpigmentation (3); mucocele (1); ulcerative stomatitis (1); salivary IgA (1); dental development (3); ANUG, herpes simplex, Kaposi sarcoma (no studies)
Study designsCase-control observational studies with full-text reports in English12 case-control studies (10 low risk of bias, 2 severe risk of bias by ROBINS-I)
TimingNot specifiedCross-sectional (case-control)

Search date: Inception to 29 July 2022. Databases: Ovid Embase, Ovid MEDLINE, PubMed, Scopus (plus reference-list hand searching)

Questions and results

Living with HIV and undergoing antiretroviral therapy (ART/HAART) vs Healthy HIV-negative controls

Population: Children and adolescents (<18 years)
20 questions
OutcomeEffectEvidenceStatus / GRADE
Mucosal (oral) hyperpigmentation
Cross-sectional (case-control; single time point)
CLWH on ART had significantly higher prevalence of mucosal hyperpigmentation than healthy controls (pooled OR 20.35, 95% CI 3.86 to 107.39); the authors described the certainty as low.
Source: Table 2 (Other oral health-related diseases); Results 3.6; Discussion; Figure 5d · same question in other reviews
OR 20.35 [3.86, 107.39]3 studies · 407 participantsUngraded
Dental development / dental age (mineralization chronology)
Cross-sectional (case-control; single time point)
No significant overall difference in dental development between CLWH on ART and healthy controls (three studies, narrative synthesis).
Source: Results 3.9; Discussion · same question in other reviews
Three studies (Fernandes 2007, de Souza 2015, Holderbaum 2005) assessed dental age (Nolla/Willems methods); Fernandes and de Souza found no significant difference between groups; Holderbaum reported mixed sex-specific…3 studiesUngraded
Recurrent oral ulcerations (WHO clinical stage 2)
Cross-sectional (case-control; single time point)
CLWH on ART had significantly higher prevalence of recurrent oral ulcerations than healthy controls (pooled OR 6.83, 95% CI 1.18 to 39.53).
Source: Table 2 (WHO clinical staging 2); Results 3.6; Figure 5a · same question in other reviews
OR 6.83 [1.18, 39.53]3 studies · 284 participantsUngraded
Kaposi's sarcoma (WHO clinical stage 4)
Cross-sectional (case-control; single time point)
No eligible studies reported Kaposi's sarcoma.
Source: Table 2 (WHO clinical staging 4) · same question in other reviews
Planned WHO stage 4 outcome; no eligible studies (Table 2 lists 'None').0 studiesNo studies
Acute necrotizing ulcerative gingivitis/periodontitis (WHO clinical stage 3)
Cross-sectional (case-control; single time point)
No eligible studies reported acute necrotizing ulcerative gingivitis/periodontitis.
Source: Table 2 (WHO clinical staging 3) · same question in other reviews
Planned WHO stage 3 outcome; no eligible studies (Table 2 lists 'None').0 studiesNo studies
Chronic herpes simplex infection (WHO clinical stage 4)
Cross-sectional (case-control; single time point)
No eligible studies reported chronic herpes simplex infection.
Source: Table 2 (WHO clinical staging 4) · same question in other reviews
Planned WHO stage 4 outcome; no eligible studies (Table 2 lists 'None').0 studiesNo studies
Dental caries prevalence (DMFT/dmft/DMFS/dmfs > 0)
Cross-sectional (case-control; single time point) · Primary dentition (dmft > 0)
In primary dentition, CLWH on ART had higher caries prevalence than healthy controls (OR 1.93, 95% CI 1.34 to 2.79; single study).
Source: Table 2 (Dental caries prevalence and severity); Results 3.4 · same question in other reviews
OR 1.93 [1.34, 2.79]1 study · 564 participantsUngraded
Oral hairy leukoplakia (WHO clinical stage 3)
Cross-sectional (case-control; single time point)
No difference in oral hairy leukoplakia between groups (pooled OR 1.00, 95% CI 0.06 to 16.19); lesion essentially absent in both.
Source: Table 2 (WHO clinical staging 3); Results 3.6; Figure 6b · same question in other reviews
OR 1.00 [0.06, 16.19]2 studies · 217 participantsUngraded
Periodontal disease (gingivitis/periodontitis)
Cross-sectional (case-control; single time point)
CLWH on ART had significantly higher prevalence of periodontal disease than healthy controls (pooled OR 3.11, 95% CI 1.62 to 5.97; moderate heterogeneity).
Source: Table 2 (Oral hygiene and periodontal status); Results 3.5; Figure 4 · same question in other reviews
OR 3.11 [1.62, 5.97]2 studies · 250 participantsUngraded
Dental caries prevalence (DMFT/dmft/DMFS/dmfs > 0)
Cross-sectional (case-control; single time point) · Permanent dentition (DMFT > 0)
In permanent dentition, CLWH on ART had higher caries prevalence than healthy controls (OR 2.49, 95% CI 1.86 to 3.32; single study).
Source: Table 2 (Dental caries prevalence and severity); Results 3.4 · same question in other reviews
OR 2.49 [1.86, 3.32]1 study · 724 participantsUngraded
Salivary immunoglobulin A (SIgA) concentration
Cross-sectional (case-control; single time point)
No significant difference in total salivary IgA between CLWH and healthy controls, though anti-Candida SIgA was higher in HIV groups; narrative only.
Source: Results 3.7 · same question in other reviews
Pomarico 2009 reported no significant difference in total SIgA among HIV-ART, HIV-HAART, and healthy children, but significantly higher anti-Candida albicans SIgA in the two HIV groups; no effect estimate pooled.1 studyUngraded
Dental caries prevalence (DMFT/dmft/DMFS/dmfs > 0)
Cross-sectional (case-control; single time point)
Pooled analysis showed higher dental caries prevalence among CLWH on ART (OR 2.70, 95% CI 2.01 to 3.62), but the two studies were divergent and the authors concluded HIV/ART is not a predisposing factor to caries.
Source: Table 2 (Dental caries prevalence and severity); Results 3.4; Figure 3 · same question in other reviews
OR 2.70 [2.01, 3.62]2 studies · 1028 participantsUngraded
Mucocele
Cross-sectional (case-control; single time point)
No significant difference in mucocele between groups (OR 3.03, 95% CI 0.12 to 75.37; single study).
Source: Table 2 (Other oral health-related diseases); Results 3.6 · same question in other reviews
OR 3.03 [0.12, 75.37]1 study · 190 participantsUngraded
Persistent parotid enlargement (WHO clinical stage 2)
Cross-sectional (case-control; single time point)
No significant difference in persistent parotid enlargement between groups (OR 10.36, 95% CI 0.53 to 201.45; single study, very imprecise).
Source: Table 2 (WHO clinical staging 2); Results 3.6 · same question in other reviews
OR 10.36 [0.53, 201.45]1 study · 60 participantsUngraded
Ulcerative stomatitis
Cross-sectional (case-control; single time point)
One study found significantly higher ulcerative stomatitis among CLWH on ART (OR 28.59, 95% CI 1.67 to 490.32), though the estimate is very imprecise.
Source: Table 2 (Other oral health-related diseases); Results 3.6; Conclusions · same question in other reviews
OR 28.59 [1.67, 490.32]1 study · 190 participantsUngraded
Poor oral hygiene (simplified oral hygiene index, OHI-S > 3)
Cross-sectional (case-control; single time point)
No significant difference in oral hygiene between CLWH on ART and healthy controls (OR 1.23, 95% CI 0.73 to 2.07; single study).
Source: Table 2 (Oral hygiene and periodontal status); Results 3.5 · same question in other reviews
OR 1.23 [0.73, 2.07]1 study · 837 participantsUngraded
Angular cheilitis (WHO clinical stage 2)
Cross-sectional (case-control; single time point)
No significant difference in angular cheilitis prevalence between CLWH and healthy controls (pooled OR 1.95, 95% CI 0.16 to 23.65).
Source: Table 2 (WHO clinical staging 2); Results 3.6; Figure 5b · same question in other reviews
OR 1.95 [0.16, 23.65]2 studies · 224 participantsUngraded
Oral candidiasis (WHO clinical stage 3)
Cross-sectional (case-control; single time point)
CLWH on ART had markedly higher prevalence of oral candidiasis than healthy controls (pooled OR 16.94, 95% CI 5.06 to 56.70).
Source: Table 2 (WHO clinical staging 3); Results 3.6 and 3.8; Figure 5c · same question in other reviews
OR 16.94 [5.06, 56.70]5 studiesUngraded
Linear gingival erythema (WHO clinical stage 2)
Cross-sectional (case-control; single time point)
No difference in linear gingival erythema between groups (pooled OR 1.00, 95% CI 0.06 to 16.19); the lesion was essentially absent in both groups.
Source: Table 2 (WHO clinical staging 2); Results 3.6; Figure 6a · same question in other reviews
OR 1.00 [0.06, 16.19]2 studies · 224 participantsUngraded
Dental caries severity (median DMFT/dmft/DMFS/dmfs)
Cross-sectional (case-control; single time point)
One study reported higher median caries severity among CLWH under 12 years; no meta-analytic estimate was pooled.
Source: Results 3.4 · same question in other reviews
Rajonson 2017 reported significantly higher median DMFT/dmft/DMFS/dmfs among CLWH than uninfected children below 12 years; no pooled effect estimate reported.1 studyUngraded

CD4+ T-cell count <250 cells/mm3 vs CD4+ T-cell count >=250 cells/mm3

Population: Children and adolescents living with HIV on ART/HAART
1 question
OutcomeEffectEvidenceStatus / GRADE
HIV-related oral lesions
Cross-sectional (case-control; single time point) · CD4+ T-cell count <250 cells/mm3 vs higher
Lower CD4+ counts (<250 cells/mm3) were associated with roughly twice the odds of HIV-related oral lesions in two studies (not pooled).
Source: Results 3.10; Table 2 · same question in other reviews
CLWH with CD4+ <250 cells/mm3 were about twice as likely to have HIV-related oral lesions: Baghirath 2013 OR 1.916 (95% CI 0.613 to 2.513), p=0.001; Divakar 2015 OR 1.999 (95% CI 0.129 to 3.688), p=0.001. Not pooled.2 studiesUngraded

ART/HAART duration <3 years vs ART/HAART duration >=3 years

Population: Children and adolescents living with HIV on ART/HAART
2 questions
OutcomeEffectEvidenceStatus / GRADE
Other orofacial opportunistic infections (linear gingival erythema, hairy leukoplakia, angular cheilitis, oral ulcers)
Cross-sectional (case-control; single time point) · ART/HAART duration <3 years vs >=3 years
ART/HAART duration had minimal influence on the prevalence of orofacial opportunistic infections other than candidiasis (no significant differences).
Source: Results 3.10; Abstract · same question in other reviews
Except for candidiasis, no significant differences in the prevalence of opportunistic infection manifestations (linear gingival erythema, hairy leukoplakia, angular cheilitis, oral ulcers) between ART duration <3 years…2 studiesUngraded
Oral candidiasis
Cross-sectional (case-control; single time point) · ART/HAART duration <3 years vs >=3 years
Oral candidiasis prevalence differed by ART duration (OR 17.93, 95% CI 3.69 to 83.12).
Source: Results 3.10; Table 2 · same question in other reviews
OR 17.93 [3.69, 83.12]2 studiesUngraded

CD4+ T-cell count below 250 cells/mm3

Population: Children living with HIV receiving ART
2 questions
OutcomeEffectEvidenceStatus / GRADE
HIV-related oral lesions
CD4+ T-cell count below 250 cells/mm3
One reported study did not show a clear difference in HIV-related oral lesions for children with CD4+ T-cell counts below 250 cells/mm3.
Source: Results 3.10 (Baghirath 2013) · same question in other reviews
OR 1.916 [0.613, 2.513]1 studyUngraded
HIV-related oral lesions
CD4+ T-cell count below 250 cells/mm3
One reported study did not show a clear difference in HIV-related oral lesions for children with CD4+ T-cell counts below 250 cells/mm3.
Source: Results 3.10 (Divakar 2015) · same question in other reviews
OR 1.999 [0.129, 3.688]1 studyUngraded

Included primary studies 21

Open as a trial list
StudyAlso included byOutcomes it informs hereTrial PICOResults
Cerqueira et al., 2010
Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the…
PMID:20040023
1 other reviewnot statednot extracted yetnot extracted yet
Ponnam et al., 2012
Oral manifestations of human immunodeficiency virus in children: An institutional study at highly active antiretroviral therapy centre in…
PMID:22923890
1 other reviewnot statednot extracted yetnot extracted yet
Rajonson et al., 2017
High prevalence of dental caries among HIV-infected children in West Africa compared to uninfected siblings.
PMID:28233316
1 other reviewnot statednot extracted yetnot extracted yet
Baghirath 2013
Oral manifestations of HIV in children receiving anti-retroviral therapy in Hyderabad, India
DOI:10.1007/s40368-013-0028-5
this review onlynot statednot extracted yetnot extracted yet
Baghirath et al., 2013
Oral manifestations of HIV in children receiving anti-retroviral therapy in Hyderabad, India.
PMID:23760809
this review onlynot statednot extracted yetnot extracted yet
Bosco & Birman, 2002
Oral manifestations in children with AIDS and in controls.
PMID:11938722
this review onlynot statednot extracted yetnot extracted yet
Bosco 2002
Oral manifestations in children with AIDS and in controls
DOI:10.1590/s1517-74912002000100002
this review onlynot statednot extracted yetnot extracted yet
Bosco 2003
Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance
DOI:10.1590/s1517-74912003000300004
this review onlynot statednot extracted yetnot extracted yet
Bosco et al., 2003
Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance.
PMID:14762498
this review onlynot statednot extracted yetnot extracted yet
Cerqueira 2010
Oral<i>Candida</i>colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in…
DOI:10.1111/j.1600-0714.2009.00857.x
this review onlynot statednot extracted yetnot extracted yet
de Souza 2015
Dental age estimation in Brazilian HIV children using Willems’ method
DOI:10.1016/j.forsciint.2015.07.044
this review onlynot statednot extracted yetnot extracted yet
de Souza et al., 2015
Dental age estimation in Brazilian HIV children using Willems' method.
PMID:26318404
this review onlynot statednot extracted yetnot extracted yet
Divakar et al., 2015
Oral manifestations in human immunodefi ciency virus infected pediatric patients receiving and not receiving antiretroviral therapy: a…
DOI:10.13112/pc.2015.23
this review onlynot statednot extracted yetnot extracted yet
Fernandes 2007
Radiographic evaluation of the chronological development of permanent dentition in children infected with HIV
DOI:10.1007/s00784-007-0124-1
this review onlynot statednot extracted yetnot extracted yet
Fernandes et al., 2007
Radiographic evaluation of the chronological development of permanent dentition in children infected with HIV.
PMID:17522900
this review onlynot statednot extracted yetnot extracted yet
Holderbaum 2005
Comparison among dental, skeletal and chronological development in HIV-positive children: a radiographic study
DOI:10.1590/s1806-83242005000300010
this review onlynot statednot extracted yetnot extracted yet
Holderbaum et al., 2005
Comparison among dental, skeletal and chronological development in HIV-positive children: a radiographic study.
PMID:16308610
this review onlynot statednot extracted yetnot extracted yet
Pomarico et al., 2009
Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A…
PMID:19615660
this review onlynot statednot extracted yetnot extracted yet
Rajonson 2017
High prevalence of dental caries among HIV‐infected children in <scp>W</scp>est <scp>A</scp>frica compared to uninfected siblings
DOI:10.1111/jphd.12203
this review onlynot statednot extracted yetnot extracted yet
Subramaniam 2015
Levels of Salivary Immunoglobulin A (SIgA) in HIV Infected Children
DOI:10.17796/1053-4628-39.4.377
this review onlynot statednot extracted yetnot extracted yet
Subramaniam et al., 2015
Levels of Salivary Immunoglobulin A (SIgA) in HIV Infected Children.
PMID:26161611
this review onlynot statednot extracted yetnot extracted yet

Overlap with other reviews

Reviews that include the same primary studies are not independent evidence. Shared counts match studies by PMID, DOI or NCT, and otherwise by author and year (a probable match).